Product Images Divalproex Sodium
View Photos of Packaging, Labels & Appearance
- structure - divalproex sodium de figure 1
- figure1 - divalproex sodium de figure 2
- figure2 - divalproex sodium de figure 3
- figure3 - divalproex sodium de figure 4
- figure4 - divalproex sodium de figure 5
- label1 - divalproex sodium de figure 6
- label2 - divalproex sodium de figure 7
- label3 - divalproex sodium de figure 8
Product Label Images
The following 8 images provide visual information about the product associated with Divalproex Sodium NDC 69452-433 by Bionpharma Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structure - divalproex sodium de figure 1
figure1 - divalproex sodium de figure 2
figure2 - divalproex sodium de figure 3
figure3 - divalproex sodium de figure 4
figure4 - divalproex sodium de figure 5
label1 - divalproex sodium de figure 6
This is a description of Divalproex Sodium Delayed-Release Tablets, USP, used for valproic acid activity. Each tablet contains Divalproex sodium USP equivalent to valproic acid 125 mg. The medication guide should be dispensed to each patient. The tablets should be stored in a tight, light-resistant container at 20° to 25°C. The product should not be accepted if the seal over the bottle opening is broken or missing. Distributed by Bionpharma Inc. It is made in India.*
label2 - divalproex sodium de figure 7
This text is a product description for tablets containing Divalproex sodium, indicated for certain conditions. It provides information on dosing, storage instructions, and a reminder to keep the medication out of reach of children. The tablets are enteric-coated and delayed-release. The text indicates that they must be dispensed in a tight, light-resistant container and stored at a specified temperature range.*
label3 - divalproex sodium de figure 8
This is a description of Divalproex Sodium Delayed-Release Tablets, USP with a strength of 500 mg. Each tablet contains Divalproex sodium USP equivalent to valproic acid. It is dispensed in a USP tight, light-resistant container and should be stored at 20° to 25°C (68° to 77°F). The packaging includes information on how to handle the medication properly and warns about keeping it out of reach of children. This medication is distributed by Bionpharma Inc., and the manufacturing location is in India. For full prescribing information, refer to the enclosed documentation.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
